291 related articles for article (PubMed ID: 15242767)
1. DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium.
Plachot C; Lelièvre SA
Exp Cell Res; 2004 Aug; 298(1):122-32. PubMed ID: 15242767
[TBL] [Abstract][Full Text] [Related]
2. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase activity is required for embryonic stem cell differentiation.
Lee JH; Hart SR; Skalnik DG
Genesis; 2004 Jan; 38(1):32-8. PubMed ID: 14755802
[TBL] [Abstract][Full Text] [Related]
4. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
5. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation.
Brero A; Easwaran HP; Nowak D; Grunewald I; Cremer T; Leonhardt H; Cardoso MC
J Cell Biol; 2005 Jun; 169(5):733-43. PubMed ID: 15939760
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation and histone acetylation patterns in cultured bovine fibroblasts for nuclear transfer.
Giraldo AM; Lynn JW; Purpera MN; Godke RA; Bondioli KR
Mol Reprod Dev; 2007 Dec; 74(12):1514-24. PubMed ID: 17440941
[TBL] [Abstract][Full Text] [Related]
7. MBD2 and MeCP2 regulate distinct transitions in the stage-specific differentiation of olfactory receptor neurons.
Macdonald JL; Verster A; Berndt A; Roskams AJ
Mol Cell Neurosci; 2010 May; 44(1):55-67. PubMed ID: 20188178
[TBL] [Abstract][Full Text] [Related]
8. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
[TBL] [Abstract][Full Text] [Related]
9. FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation.
Song MR; Ghosh A
Nat Neurosci; 2004 Mar; 7(3):229-35. PubMed ID: 14770186
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
11. Chromatin assembly factor 1 interacts with histone H3 methylated at lysine 79 in the processes of epigenetic silencing and DNA repair.
Zhou H; Madden BJ; Muddiman DC; Zhang Z
Biochemistry; 2006 Mar; 45(9):2852-61. PubMed ID: 16503640
[TBL] [Abstract][Full Text] [Related]
12. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
13. Gene silencing. Methylation meets acetylation.
Bestor TH
Nature; 1998 May; 393(6683):311-2. PubMed ID: 9620794
[No Abstract] [Full Text] [Related]
14. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
Travaglini L; Vian L; Billi M; Grignani F; Nervi C
Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
[TBL] [Abstract][Full Text] [Related]
16. [Epigenetic regulation involved in fate specification of neural cells].
Sanosaka T; Tsujimura K; Nakashima K
Tanpakushitsu Kakusan Koso; 2008 Mar; 53(4 Suppl):331-7. PubMed ID: 21089300
[No Abstract] [Full Text] [Related]
17. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
18. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
Esfandiari F; Green R; Cotterman RF; Pogribny IP; James SJ; Miller JW
Carcinogenesis; 2003 Dec; 24(12):1935-40. PubMed ID: 12949043
[TBL] [Abstract][Full Text] [Related]
19. Alterations in epigenetic modifications during oocyte growth in mice.
Kageyama S; Liu H; Kaneko N; Ooga M; Nagata M; Aoki F
Reproduction; 2007 Jan; 133(1):85-94. PubMed ID: 17244735
[TBL] [Abstract][Full Text] [Related]
20. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
